Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof
AssigneeTechnion Research & Development Foundation Limited
InventorsMoshe Gavish, Jehuda Arieh Veenman, Alex Shterenberg, Ilan Marek
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel quinoxaline, quinazoline and phthalazine derivatives as well as multimeric derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds for the treatment and prevention of brain damage resulting from brain injury, especially secondary brain damage due to traumatic brain injury (TBI). The compounds of the invention are also useful in treating and preventing neurodegenerative diseases.
Claims13
A compound represented by the structure of Formula II:
- wherein
- R1 is oxo, R2 is a group of the formula A and is a single bond;
- or R1 is a group of the formula A, R2 is absent and is a double bond;
- A is represented by the structure:
- R3 and R4 are each independently selected from the group consisting of a linear or branched C1-C6 alkyl, a linear or branched C2-C6 alkenyl, a C3-C8 cycloalkyl, heterocyclyl, aryl, heteroaryl, halo, hydroxy, alkoxy, aryloxy, amino, cyano and nitro;
- R5 and R6 are each independently selected from the group consisting of hydrogen, a linear or branched C1-C6 alkyl, a linear or branched C2-C6 alkenyl, a C3-C8 cycloalkyl, heterocyclyl, aryl and heteroaryl;
- X is selected from the group consisting of a bond, —O—, —S—, and —CR8R9, wherein R8 and R9 are independently selected from the group consisting of hydrogen and a linear or branched C1-C6 alkyl;
- m is 0, 1, 2, 3 or 4;
- and
- n is 0, 1, 2, 3, 4 or 5;
- including salts, optical isomers, geometrical isomers, enantiomers, diastereomers, and mixtures thereof.
Dependencies are inferred from the claim text.